The burden and risks of emerging complications of diabetes mellitus

D Tomic, JE Shaw, DJ Magliano - Nature Reviews Endocrinology, 2022 - nature.com
The traditional complications of diabetes mellitus are well known and continue to pose a
considerable burden on millions of people living with diabetes mellitus. However, advances …

Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis

ZL Teo, YC Tham, M Yu, ML Chee, TH Rim, N Cheung… - Ophthalmology, 2021 - Elsevier
Topic To provide updated estimates on the global prevalence and number of people with
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …

The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors

RA DeFronzo, WB Reeves, AS Awad - Nature Reviews Nephrology, 2021 - nature.com
Diabetic kidney disease is the leading cause of kidney failure worldwide; in the USA, it
accounts for over 50% of individuals entering dialysis or transplant programmes. Unlike …

Interpreting global trends in type 2 diabetes complications and mortality

MK Ali, J Pearson-Stuttard, E Selvin, EW Gregg - Diabetologia, 2022 - Springer
International trends in traditional diabetes complications (cardiovascular, renal, peripheral
vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly …

Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results …

S Safiri, N Karamzad, JS Kaufman, AW Bell… - Frontiers in …, 2022 - frontiersin.org
Aim To report the point prevalence, deaths and disability-adjusted-life-years (DALYs) due to
type 2 diabetes and its attributable risk factors in 204 countries and territories during the …

Advanced bandages for diabetic wound healing

S Matoori, A Veves, DJ Mooney - Science translational medicine, 2021 - science.org
Current treatment options for foot ulcers, a serious and prevalent complication of diabetes,
remain nonspecific. In this Perspective, we present recent advances in understanding the …

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

HC Gerstein, HM Colhoun, GR Dagenais, R Diaz… - The Lancet, 2019 - thelancet.com
Background Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce
cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high …

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …

F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American …

CE Ndumele, IJ Neeland, KR Tuttle, SL Chow… - Circulation, 2023 - Am Heart Assoc
A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors
such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led …